Related Experiment Videos
A functional observational battery for use in canine toxicity studies: development and validation.
International Journal of Toxicology
|December 19, 2003
Summary
A new noninvasive screening method for dogs detects neurotoxic and neuropharmacologic effects. This standardized approach improves safety assessments in drug development by providing accurate dose-response metrics.
Area of Science:
- Veterinary Toxicology
- Neuropharmacology
- Regulatory Science
Background:
- Dogs, particularly beagles, are the standard nonrodent species for regulatory toxicity studies.
- A standardized neurobehavioral screen (functional observational battery) exists for rodents but not for nonrodents.
- Limited progress has been made in developing similar screens for dogs in pharmaceutical research.
Purpose of the Study:
- To develop a robust, sensitive, and noninvasive screening methodology for detecting neurotoxic and neuropharmacologic effects in dogs.
- To enable initial quantitation and characterization of these effects.
- To adapt an analysis component for differentiating neurotoxic from neuropharmacologic activities.
Main Methods:
- Development of a novel noninvasive screening methodology for canine neurotoxicity and neuropharmacology.
- Adaptation of an analysis and interpretation component for differentiating neurotoxic from neuropharmacologic activities.
- Discussion of comparative species differences in sensitivity to neuroactive agents.
Main Results:
- A robust and sensitive noninvasive screening methodology for detecting neurotoxic and neuropharmacologic effects in dogs has been developed.
- The methodology allows for initial quantitation and characterization of these effects.
- An analysis component to differentiate neurotoxic from neuropharmacologic activities has been adapted.
Conclusions:
- The developed screening methodology offers a valuable tool for assessing neurotoxicity and neuropharmacology in dogs.
- This approach can simplify and improve the accuracy of dose/response metrics in regulatory studies.
- Integration into existing study designs, especially safety pharmacology evaluations, is feasible without increasing animal usage.